View in EDS

CD8 PET imaging with [89Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study.

Saved in:
Bibliographic Details
Title: CD8 PET imaging with [89Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study.
Authors: Postow MA; Memorial Sloan Kettering Cancer Center, New York, New York, USA postowm@mskcc.org., Zang PD; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA., Pal SK; City of Hope Comprehensive Cancer Center, Duarte, California, USA., Mauguen A; Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Farwell M; Division of Nuclear Medicine and Molecular Imaging, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Gordon M; HonorHealth, Scottsdale, Arizona, USA., Hays D; CARTI Cancer Center, Little Rock, Arkansas, USA., Wong JYC; Department of Radiation Oncology, City of Hope Beckman Research Institute and Medical Center, Duarte, California, USA., Chen D; University of Washington, Seattle, Washington, USA., Ulaner GA; Department of Molecular Imaging Departments of Radiology and Translational Genomics, Therapy Hoag Family Cancer Institute, Irvine Los Angeles, California, USA.; Department of Molecular Imaging Departments of Radiology and Translational Genomics, University of Southern California, Los Angeles, California, USA., Esposito G; MedStar Georgetown University Hospital, Washington, DC, USA., McConathy J; University of Alabama at Birmingham Health System Authority, Birmingham, Alabama, USA., Graham MM; Department of Radiology, University of Iowa, Iowa city, Iowa, USA., Shields AF; Karmanos Cancer Institute, Detroit, Michigan, USA., Van den Abbeele AD; Department of Imaging, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Butler MO; Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada., Thomas JS; USC Norris Comprehensive Cancer Center, Los Angeles, California, USA., Twardowski P; Department of Urologic Oncology, Providence Saint John's Health Center, Santa Monica, California, USA., Narang J; Takeda Pharmaceuticals, Cambridge, Massachusetts, USA., Singh AP; Oncology Cell Therapy and Therapeutic Area Unit, Waltham, Massachusetts, USA., Dey A; Oncology Cell Therapy and Therapeutic Area Unit, Waltham, Massachusetts, USA., Maresca KP; WRDM, Pfizer Inc, Tewksbury, Massachusetts, USA., Keliher E; Pfizer Inc, New York, New York, USA., Liu F; Clinical Pharmacology and Translational Sciences, Pfizer Oncology Division, La Jolla, California, USA., Potdevin G; AstraZeneca US, Wilmington, Delaware, USA., Schmidt G; AstraZeneca US, Wilmington, Delaware, USA., Le W; ImaginAb Inc, Inglewood, California, USA., Wilson I; ImaginAb Inc, Inglewood, California, USA., Mascioni A; ImaginAb Inc, Inglewood, California, USA., Jia F; ImaginAb Inc, Inglewood, California, USA., Korn R; Radiology, Imaging Endpoints, Scottsdale, Arizona, USA., Ferris MR; ImaginAb Inc, Inglewood, California, USA., Schmiedehausen K; ImaginAb Inc, Inglewood, California, USA., Pandit-Taskar N; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Margolin KA; Medical Oncology, City of Hope National Medical Center, duarte, California, USA.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2026 Mar 27; Vol. 14 (3). Date of Electronic Publication: 2026 Mar 27.
Publication Type: Journal Article; Multicenter Study; Clinical Trial, Phase II
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41895717
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CD8 PET imaging with [<superscript>89</superscript>Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Postow+MA%22">Postow MA</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York, USA postowm@mskcc.org.<br /><searchLink fieldCode="AU" term="%22Zang+PD%22">Zang PD</searchLink>; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA.<br /><searchLink fieldCode="AU" term="%22Pal+SK%22">Pal SK</searchLink>; City of Hope Comprehensive Cancer Center, Duarte, California, USA.<br /><searchLink fieldCode="AU" term="%22Mauguen+A%22">Mauguen A</searchLink>; Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Farwell+M%22">Farwell M</searchLink>; Division of Nuclear Medicine and Molecular Imaging, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Gordon+M%22">Gordon M</searchLink>; HonorHealth, Scottsdale, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Hays+D%22">Hays D</searchLink>; CARTI Cancer Center, Little Rock, Arkansas, USA.<br /><searchLink fieldCode="AU" term="%22Wong+JYC%22">Wong JYC</searchLink>; Department of Radiation Oncology, City of Hope Beckman Research Institute and Medical Center, Duarte, California, USA.<br /><searchLink fieldCode="AU" term="%22Chen+D%22">Chen D</searchLink>; University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Ulaner+GA%22">Ulaner GA</searchLink>; Department of Molecular Imaging Departments of Radiology and Translational Genomics, Therapy Hoag Family Cancer Institute, Irvine Los Angeles, California, USA.; Department of Molecular Imaging Departments of Radiology and Translational Genomics, University of Southern California, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Esposito+G%22">Esposito G</searchLink>; MedStar Georgetown University Hospital, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22McConathy+J%22">McConathy J</searchLink>; University of Alabama at Birmingham Health System Authority, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Graham+MM%22">Graham MM</searchLink>; Department of Radiology, University of Iowa, Iowa city, Iowa, USA.<br /><searchLink fieldCode="AU" term="%22Shields+AF%22">Shields AF</searchLink>; Karmanos Cancer Institute, Detroit, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Van+den+Abbeele+AD%22">Van den Abbeele AD</searchLink>; Department of Imaging, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Butler+MO%22">Butler MO</searchLink>; Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Thomas+JS%22">Thomas JS</searchLink>; USC Norris Comprehensive Cancer Center, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Twardowski+P%22">Twardowski P</searchLink>; Department of Urologic Oncology, Providence Saint John's Health Center, Santa Monica, California, USA.<br /><searchLink fieldCode="AU" term="%22Narang+J%22">Narang J</searchLink>; Takeda Pharmaceuticals, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Singh+AP%22">Singh AP</searchLink>; Oncology Cell Therapy and Therapeutic Area Unit, Waltham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Dey+A%22">Dey A</searchLink>; Oncology Cell Therapy and Therapeutic Area Unit, Waltham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Maresca+KP%22">Maresca KP</searchLink>; WRDM, Pfizer Inc, Tewksbury, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Keliher+E%22">Keliher E</searchLink>; Pfizer Inc, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Liu+F%22">Liu F</searchLink>; Clinical Pharmacology and Translational Sciences, Pfizer Oncology Division, La Jolla, California, USA.<br /><searchLink fieldCode="AU" term="%22Potdevin+G%22">Potdevin G</searchLink>; AstraZeneca US, Wilmington, Delaware, USA.<br /><searchLink fieldCode="AU" term="%22Schmidt+G%22">Schmidt G</searchLink>; AstraZeneca US, Wilmington, Delaware, USA.<br /><searchLink fieldCode="AU" term="%22Le+W%22">Le W</searchLink>; ImaginAb Inc, Inglewood, California, USA.<br /><searchLink fieldCode="AU" term="%22Wilson+I%22">Wilson I</searchLink>; ImaginAb Inc, Inglewood, California, USA.<br /><searchLink fieldCode="AU" term="%22Mascioni+A%22">Mascioni A</searchLink>; ImaginAb Inc, Inglewood, California, USA.<br /><searchLink fieldCode="AU" term="%22Jia+F%22">Jia F</searchLink>; ImaginAb Inc, Inglewood, California, USA.<br /><searchLink fieldCode="AU" term="%22Korn+R%22">Korn R</searchLink>; Radiology, Imaging Endpoints, Scottsdale, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Ferris+MR%22">Ferris MR</searchLink>; ImaginAb Inc, Inglewood, California, USA.<br /><searchLink fieldCode="AU" term="%22Schmiedehausen+K%22">Schmiedehausen K</searchLink>; ImaginAb Inc, Inglewood, California, USA.<br /><searchLink fieldCode="AU" term="%22Pandit-Taskar+N%22">Pandit-Taskar N</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Margolin+KA%22">Margolin KA</searchLink>; Medical Oncology, City of Hope National Medical Center, duarte, California, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2026 Mar 27; Vol. 14 (3). <i>Date of Electronic Publication: </i>2026 Mar 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Clinical Trial, Phase II
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41895717
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2025-012208
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: CD8 PET imaging with [89Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Postow MA
      – PersonEntity:
          Name:
            NameFull: Zang PD
      – PersonEntity:
          Name:
            NameFull: Pal SK
      – PersonEntity:
          Name:
            NameFull: Mauguen A
      – PersonEntity:
          Name:
            NameFull: Farwell M
      – PersonEntity:
          Name:
            NameFull: Gordon M
      – PersonEntity:
          Name:
            NameFull: Hays D
      – PersonEntity:
          Name:
            NameFull: Wong JYC
      – PersonEntity:
          Name:
            NameFull: Chen D
      – PersonEntity:
          Name:
            NameFull: Ulaner GA
      – PersonEntity:
          Name:
            NameFull: Esposito G
      – PersonEntity:
          Name:
            NameFull: McConathy J
      – PersonEntity:
          Name:
            NameFull: Graham MM
      – PersonEntity:
          Name:
            NameFull: Shields AF
      – PersonEntity:
          Name:
            NameFull: Van den Abbeele AD
      – PersonEntity:
          Name:
            NameFull: Butler MO
      – PersonEntity:
          Name:
            NameFull: Thomas JS
      – PersonEntity:
          Name:
            NameFull: Twardowski P
      – PersonEntity:
          Name:
            NameFull: Narang J
      – PersonEntity:
          Name:
            NameFull: Singh AP
      – PersonEntity:
          Name:
            NameFull: Dey A
      – PersonEntity:
          Name:
            NameFull: Maresca KP
      – PersonEntity:
          Name:
            NameFull: Keliher E
      – PersonEntity:
          Name:
            NameFull: Liu F
      – PersonEntity:
          Name:
            NameFull: Potdevin G
      – PersonEntity:
          Name:
            NameFull: Schmidt G
      – PersonEntity:
          Name:
            NameFull: Le W
      – PersonEntity:
          Name:
            NameFull: Wilson I
      – PersonEntity:
          Name:
            NameFull: Mascioni A
      – PersonEntity:
          Name:
            NameFull: Jia F
      – PersonEntity:
          Name:
            NameFull: Korn R
      – PersonEntity:
          Name:
            NameFull: Ferris MR
      – PersonEntity:
          Name:
            NameFull: Schmiedehausen K
      – PersonEntity:
          Name:
            NameFull: Pandit-Taskar N
      – PersonEntity:
          Name:
            NameFull: Margolin KA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 03
              Text: 2026 Mar 27
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1